The Reactome Pathway Knowledgebase 2024.

Journal: Nucleic acids research
PMID:

Abstract

The Reactome Knowledgebase (https://reactome.org), an Elixir and GCBR core biological data resource, provides manually curated molecular details of a broad range of normal and disease-related biological processes. Processes are annotated as an ordered network of molecular transformations in a single consistent data model. Reactome thus functions both as a digital archive of manually curated human biological processes and as a tool for discovering functional relationships in data such as gene expression profiles or somatic mutation catalogs from tumor cells. Here we review progress towards annotation of the entire human proteome, targeted annotation of disease-causing genetic variants of proteins and of small-molecule drugs in a pathway context, and towards supporting explicit annotation of cell- and tissue-specific pathways. Finally, we briefly discuss issues involved in making Reactome more fully interoperable with other related resources such as the Gene Ontology and maintaining the resulting community resource network.

Authors

  • Marija Milacic
    Ontario Institute for Cancer Research, Toronto, ON, M5G 0A3, Canada.
  • Deidre Beavers
    Oregon Health and Science University, Portland, OR 97239, USA.
  • Patrick Conley
    Oregon Health and Science University, Portland, OR 97239, USA.
  • Chuqiao Gong
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK.
  • Marc Gillespie
    Ontario Institute for Cancer Research, Toronto, ON, M5G 0A3, Canada.
  • Johannes Griss
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK; Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria.
  • Robin Haw
    Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
  • Bijay Jassal
    Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Lisa Matthews
    Department of Biochemistry & Molecular Pharmacology, NYU. Langone Medical Center, New York, NY, United States.
  • Bruce May
    Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
  • Robert Petryszak
    EMBL-European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SD, UK.
  • Eliot Ragueneau
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire, CB10 1SD, UK.
  • Karen Rothfels
    Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada.
  • Cristoffer Sevilla
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton CB10 1SD, UK.
  • Veronica Shamovsky
    Department of Biochemistry & Molecular Pharmacology, NYU School of Medicine, New York, New York, United States of America.
  • Ralf Stephan
    Ontario Institute for Cancer Research, Toronto, ON M5G0A3, Canada.
  • Krishna Tiwari
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
  • Thawfeek Varusai
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
  • Joel Weiser
    Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Adam Wright
    Harvard Medical School, Boston, MA; Brigham and Women's Hospital, Boston, MA.
  • Guanming Wu
    Oregon Health Sciences University, Portland, OR, United States.
  • Lincoln Stein
    Informatics and Bio-computing, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Henning Hermjakob
    European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.
  • Peter D'Eustachio
    Department of Biochemistry & Molecular Pharmacology, NYU. Langone Medical Center, New York, NY, United States.